bims-cytox1 Biomed news
on Cytochrome oxidase subunit 1
Issue of 2018‒07‒22
one paper selected by
Gavin McStay
Staffordshire University

  1. Asia Pac J Ophthalmol (Phila). 2018 Jul 15.
    Kim US, Jurkute N, Yu-Wai-Man P.
      Leber hereditary optic neuropathy (LHON) is an important cause of mitochondrial blindness. The majority of patients harbor one of three mitochondrial DNA (mtDNA) point mutations, m.3460G>A, m.11778G>A, and m.14484T>C, which all affect complex I subunits of the mitochondrial respiratory chain. The loss of retinal ganglion cells in LHON is thought to arise from a combination of impaired mitochondrial oxidative phosphorylation resulting in decreased adenosine triphosphate (ATP) production and increased levels of reactive oxygen species. Treatment options for LHON remain limited, but major advances in mitochondrial neuroprotection, gene therapy, and the prevention of transmission of pathogenic mtDNA mutations will hopefully translate into tangible benefits for patients affected by this condition and their families.
    Keywords:  LHON; Leber hereditary optic neuropathy; gene therapy; idebenone; mitochondrial donation; neuroprotection; retinal ganglion cells